We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-0.98%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$876M
AUM Growth
-$55.2M
(-5.9%)
Cap. Flow
-$22.6M
Cap. Flow
% of AUM
-2.58%
Top 10 Holdings %
Top 10 Hldgs %
15.65%
Holding
1,097
New
348
Increased
154
Reduced
158
Closed
436
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$13.9M |
| 2 |
CVS Health
CVS
|
+$12.2M |
| 3 |
Meta Platforms (Facebook)
META
|
+$11.6M |
| 4 |
Skyworks Solutions
SWKS
|
+$10.5M |
| 5 |
Nike
NKE
|
+$9.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$27.9M |
| 2 |
Starbucks
SBUX
|
+$11.8M |
| 3 |
Goldman Sachs
GS
|
+$10.9M |
| 4 |
Coca-Cola
KO
|
+$8.98M |
| 5 |
T-Mobile US
TMUS
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Healthcare | 13.88% |
| 3 | Consumer Discretionary | 12.26% |
| 4 | Financials | 8.85% |
| 5 | Communication Services | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NARI
276
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $726K | 0.08% |
+11,100
| New | +$698K |
|
277
Stride
LRN
$3.83B
| $725K | 0.08% |
16,107
+5,800
| +56% | +$236K |
|
278
Oshkosh
OSK
$9.66B
| $725K | 0.08% |
7,600
+4,991
| +191% | +$484K |
|
279
Genuine Parts
GPC
$17.6B
| $724K | 0.08% |
+5,015
| New | +$779K |
|
280
Public Service Enterprise Group
PEG
$39.5B
| $723K | 0.08% |
12,700
-38,344
| -75% | -$2.36M |
|
281
Array Technologies
ARRY
$848M
| $719K | 0.08% |
+32,406
| New | +$704K |
|
282
Fortune Brands Innovations
FBIN
$6.14B
| $713K | 0.08% |
11,473
+1,300
| +13% | +$89.3K |
|
283
Unilever
UL
$132B
| $712K | 0.08% |
+12,818
| New | +$741K |
|
284
Progressive
PGR
$125B
| $710K | 0.08% |
+5,100
| New | +$671K |
|
285
Baidu
BIDU
$35.8B
| $707K | 0.08% |
+5,266
| New | +$738K |
|
286
Live Nation Entertainment
LYV
$41.7B
| $706K | 0.08% |
8,500
-22,200
| -72% | -$1.93M |
|
287
Elanco Animal Health
ELAN
$12.7B
| $703K | 0.08% |
+62,541
| New | +$726K |
|
288
Progyny
PGNY
$2.47B
| $701K | 0.08% |
20,596
+11,796
| +134% | +$445K |
|
289
Bank OZK
OZK
$5.5B
| $701K | 0.08% |
18,899
+6,300
| +50% | +$255K |
|
290
Encompass Health
EHC
$11.3B
| $698K | 0.08% |
10,400
-3,100
| -23% | -$213K |
|
291
Generac Holdings
GNRC
$11.6B
| $697K | 0.08% |
6,400
-6,174
| -49% | -$764K |
|
|
ICPT
292
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $693K | 0.08% |
+37,400
| New | +$423K |
|
293
Fox Class B
FOX
$21.3B
| $693K | 0.08% |
+23,986
| New | +$734K |
|
294
Cameco
CCJ
$38.9B
| $690K | 0.08% |
+17,400
| New | +$616K |
|
295
Chegg
CHGG
$110M
| $687K | 0.08% |
+77,000
| New | +$751K |
|
296
Urban Outfitters
URBN
$6.22B
| $683K | 0.08% |
20,900
-22,900
| -52% | -$784K |
|
297
Conagra Brands
CAG
$7.29B
| $683K | 0.08% |
24,900
-58,400
| -70% | -$1.8M |
|
298
Axalta
AXTA
$7.22B
| $675K | 0.08% |
+25,102
| New | +$736K |
|
299
BioNTech
BNTX
$23B
| $674K | 0.08% |
+6,200
| New | +$686K |
|
300
Robinhood
HOOD
$85.9B
| $672K | 0.08% |
68,500
-61,800
| -47% | -$686K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Bayesian Capital Management held 1,097 positions worth $876M, down 5.9% from $931M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bayesian Capital Management's Q3 2023 filing shows 348 new, 154 increased, 158 reduced and 436 closed positions. Its largest new stake was Walt Disney: 162,687 shares worth $13.2M. The largest sale was NVIDIA, an estimated $27.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Bayesian Capital Management's largest Q3 2023 buy was Walt Disney: 162,687 shares worth $13.2M.
- Bayesian Capital Management added most to CVS Health in Q3 2023, an estimated $12.2M increase.
- Bayesian Capital Management's biggest Q3 2023 reduction was Coca-Cola, cutting an estimated $8.98M.
- Bayesian Capital Management fully exited NVIDIA in Q3 2023, selling an estimated $27.9M.
- Bayesian Capital Management's ten largest holdings make up 16% of its $876M portfolio in Q3 2023.
- Bayesian Capital Management opened 348 new positions and closed 436 in Q3 2023.
- Bayesian Capital Management's portfolio value fell 5.9% quarter-over-quarter to $876M.
Based on Bayesian Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.